






Early experience with robotic mitral valve repair with
intra-aortic occlusionRisto Kes€avuori, MD, Peter Raivio, MD, PhD, Janne J. Jokinen, MD, PhD, Antero Sahlman, MD,
Kari Teittinen, MD, and Antti Vento, MD, PhDABSTRACT
Objective: To report the learning curve and early results of robotic mitral valve
repairs in comparison with propensity score–matched sternotomy controls after
the adoption of a robotic mitral valve surgery program in a university teaching
hospital.
Methods: A total of 142 patients underwent robotic mitral valve repair due to
degenerative mitral regurgitation between May 2011 and December 2015.
Control patients operated on via the conventional sternotomy approach were
selected by the use of propensity score analysis resulting in 2 well-matched study
groups.
Results: Valve repair rate was 98.6% and 97.9% in the robotic and sternotomy
groups, respectively. Operation length, cardiopulmonary bypass, aortic cross-
clamp, and ventilation times were shorter in the sternotomy group. All of these
times were statistically significantly reduced within the robotic group during
the learning curve. Even though there was no statistically significant difference
in the rate of perioperative complications between the groups, 3 patients in the
robotic group required postoperative extracorporeal membrane oxygenation due
to low cardiac output, and 1 patient in the robotic group died. In the robotic
and sternotomy groups, 86.3% versus 84.7% of patients had grade 1þ mitral
valve regurgitation at the latest follow-up visit, and there was no statistically
significant difference in survival or reoperation rate between the 2 study groups
during follow-up.
Conclusions: The present series reports the entire early learning curve related to
the introduction of robotic mitral valve repair in our institution. In all, repair rate
and early durability were acceptable, but more patients in the robotic group had
serious complications. Early major robotic complications that occurred may
have been related to the simultaneous use of intra-aortic occlusion. (J Thorac Car-
diovasc Surg 2018;155:1463-71)From the Department of Cardiac Surgery, Heart and Lung Center, Helsinki University
Central Hospital, Helsinki, Finland.
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Central Message
We report the early learning curve related to the
introduction of robotic mitral valve repair.
Valve-related follow-up results were acceptable,
but some major complications occurred in the
robotic group. Early major robotic complica-
tions that occurred may have been related to
the simultaneous use of intra-aortic occlusion.Perspective
Excellent mid-term results after robotic mitral
valve repair have been reported by high-volume
centers.Our study reports the entire early learning
curve related to the introduction of robotic mitral
valve repair compared with propensity score–
matched sternotomy controls. In all, repair rate
and valve-related follow-up results were accept-
able, but some major complications occurred in
the robotic group. Early major robotic complica-
tions that occurred may have been related to the
simultaneous use of intra-aortic occlusion.See Editorial Commentary page 1472.
See Editorial page 1459.Advancements in robotic surgical instrumentation and
cardiopulmonary bypass technologies have expanded the
role of robotically assisted operations in cardiac surgery.is QR codewill take
pplemental video for
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Abbreviations and Acronyms
ECMO ¼ extracorporeal membrane oxygenator
IQR ¼ interquartile range
MR ¼ mitral valve regurgitation
SD ¼ standard deviation




Robotic methods are most widely adopted in mitral valve op-
erations due to excellent visualization of themitral valve using
the robotic approach. In robotic mitral valve surgery, access to
the heart is obtained by the use of small ports in the right inter-
costal spaces, allowing surgery to be performed with minimal
tissue trauma in comparisonwith the conventional sternotomy
approach. Suggested benefits of the robotically assisted
approach have been faster return to ordinary daily activities,
shorter length of stay, reduced pain, improved cosmesis, and
reduced need for blood transfusions. In high-volume centers,
the short-term and long-term results of robotic mitral valve
surgery have been excellent, and outcomes have been compa-
rable with the conventional sternotomy approach.1-8 Recently
published expert opinion for practice guidelines of minimally
invasive and robotic mitral valve surgery suggests that in the
beginning of the learning curve only simple mitral valve
pathologies should be operated via minimally invasive
approaches.9-11 However, in high-volume centers, the results
of complex robotic leaflet repairs have been comparable
with more simple operations with no increase in the need of
reoperations.7Also, quality of life early after surgery improves
faster after robotic operations when compared with the ster-
notomy approach, but this difference is reduced over time.12,13
The minimally invasive cardiac surgery program at the
Helsinki University Central Hospital Heart and Lung
Center was started in January 2009. The first minimally inva-
sive operations were performed videothoracoscopically via a
right mini-thoracotomy. SinceMay 2011,minimally invasive
mitral valve operations have been performed with robotic
assistance. In addition to robotic mitral valve surgery, robot-
ically assisted coronary artery bypass grafting operations and
robotically assisted operations for atrial septal defects and
myxomas also have been performed at our institution.
The objective of this study was to report the learning curve
after the adoption of a roboticmitral valve surgery program in a
university teaching hospital and to report the early results of ro-
botic mitral valve repair in comparison with propensity score–
matched sternotomy controls. Notably, in our series the use of
an endoaortic balloon was initiated at the same time with the
robotic instrumentation, which resulted in overlapping
learning curves. Also, myocardial protection methods evolved
during the learning curve.
PATIENTS AND METHODS
Patients and Data Collection
A total of 145 consecutive patients underwent robotic mitral valve
surgery at our institution between May 2011 and December 2015.1464 The Journal of Thoracic and Cardiovascular SurOperations were performed with the da Vinci Si Surgical System (Intuitive
Surgical, Inc, Sunnyvale, Calif). Altogether, 3 patients who underwent a
robotically assisted operation were excluded from this study, 2 due to a
planned mitral valve replacement and 1 due to active endocarditis. This
resulted in a study group of 142 patients who were scheduled for robotic
mitral valve repair for degenerative mitral regurgitation.
Careful patient selection was carried out when selecting patients for
robotic surgery. Exclusion criteria for robotic mitral valve surgery are listed
in Table 1. Patients with significant comorbidities or high surgical risk were
mostly operated on via the conventional sternotomy approach. To reduce
selection bias, propensity score matching was used to create 2 study groups
with similar preoperative risk profiles.14 The medical records of all patients
who underwent isolated mitral valve surgery or mitral valve surgery with
concomitant tricuspid valve annuloplasty or an atrial fibrillation ablation
procedure from the conventional sternotomy approach in our institution
between 2005 and 2015 were reviewed for the propensity score analysis.
A total of 317 sternotomy patients were included in the analysis after we
excluded patients who underwent urgent surgery, surgery for active
endocarditis, or planned mitral valve replacement. Of these patients, a
control group of 142 patients was selected using the propensity score
analysis. Patients included in the study are depicted in a flow chart
(Figure 1).
Preoperative patient characteristics of the robotic group and the
propensity-matched control group are shown in Table 2. The majority of
patients had isolated posterior leaflet pathology, but isolated anterior leaflet
and bileaflet pathologies also were present in both study groups with no
statistically significant difference between the 2 groups. All control
patients and 141 patients in the robotic group had grade 3þ or 4þ mitral
valve regurgitation (MR) preoperatively, and 1 patient in the robotic group
who underwent concomitant myxoma excision had grade 2þ MR
preoperatively. A total of 19 (13.4%) patients in the sternotomy group
and 7 (4.9%) patients in the robotic group had chronic lung disease
preoperatively (P ¼ .022). Patients with chronic obstructive pulmonary
disease were excluded from robotic surgery, which may in part explain
the observed difference. Preoperatively, all patients underwent a computed
tomography scan of the aorta and femoral vessels to exclude patients
unsuitable for robotic surgery. Echocardiographic follow-up visits were
performed mostly at 3 months and 1 year postoperatively, and all available
data from the latest follow-up visits were included in this study.
The patient data were collected from intensive care, cardiac surgery, and
cardiology databases retrospectively. Medical records related to
preoperative and postoperative care were retrieved from other hospitals
when needed. This study was approved by the local institutional board
and the local ethics committee.Surgical Technique
All robotically assisted operations were performed with the da Vinci Si
Surgical system (Intuitive Surgical, Inc). Cardiopulmonary bypass was
established by groin cannulation and aortic occlusion was performed
primarily with an endoaortic balloon. A double-lumen endotracheal tube
or a bronchial blocker was applied to allow isolated left-lung ventilation.
The camera port was placed near the mammilla, mostly in the fourth
intercostal space. The service port was placed laterally from the camera
port to the same or adjacent intercostal space. The ports for the second, first,
and third robotic arms were positioned using the 4-finger distance rule in
the third, fifth, and sixth intercostal spaces, respectively.
Bicaval venous cannulation was performed via the right femoral and
jugular veins with Medtronic, Inc (Minneapolis, Minn), Estech Systems
Inc (Plano, Tex), or Edwards Lifesciences (Irvine, Calif) venous cannulas.
Usually right-sided femoral arterial cannulation was preferred with a 21- or
23-F side branch arterial cannula (EndoReturn; Edwards Lifesciences). An
endoaortic balloon (EndoClamp or IntraClude; Edwards Lifesciences) was
positioned in the ascending aorta under echocardiographic control. The
patient’s right side was elevated 30 from the horizontal plane, and thegery c April 2018
TABLE 1. Exclusion criteria for surgery
Significant aortic, iliac, or femoral artery calcification
Tiny femoral vessels
LV dysfunction
Pulmonary artery pressure>70 mm Hg or severe RV dysfunction
Diameter of the ascending aorta>40 mm
Significant mitral annular calcification
Moderate or severe aortic regurgitation
Kyphoscoliosis and pectus excavatum
Morbid obesity




LV, Left ventricle; RV, right ventricle; COPD, chronic obstructive pulmonary disease.






da Vinci Si Surgical system was docked to the patient. After docking,
cardiopulmonary bypass was started and a pericardiotomy was performed
4 cm anterior to the phrenic nerve. The pericardium was suspended with
retraction sutures placed through angiocatheters through the thoracic wall.
Aortic occlusion was performed primarily with the endoaortic balloon,
but the Chitwood clamp (Scanlan International, Inc, St Paul, Minn) also
was used in some operations. Rapid right ventricular pacing or adenosine
was used when positioning the endoaortic balloon. Myocardial protection
methods were improved during the learning curve. Initially, the operations
were performed solely with antegrade Bretschneider cold cardioplegiaFIGURE 1. Patient flow diagram depicting mitral valve operations (isolated mi
valve annuloplasty or atrial fibrillation ablation procedure) between 2005 and 2
The Journal of Thoracic and Car(Custodiol HTK Solution; Essential Pharmaceuticals, LLC, Ewing, NJ)
via the endoaortic balloon, but in the later operations antegrade cold blood
cardioplegia was used and also retrograde cold blood cardioplegia was
delivered via a ProPlege coronary sinus catheter (Edwards Lifesciences).
The EndoClamp endoaortic balloon was replaced with the more recent
IntraClude device, and the perfusion temperature was lowered to 32C in
the later operations.
Patients in the control group underwent mitral surgery via the
conventional sternotomy approach. Cardiopulmonary bypass was
established with direct cannulation of the ascending aorta, and a cross-
clamp was used for aortic occlusion. The heart was protected with cold
ante- and retrograde blood cardioplegia. A short video of a robotic mitral
valve operation performed at our institution is presented in Video 1.
Statistical Analysis and Propensity Score Matching
IBM SPSS, version 24.0 (IBM Corp, Armonk, NY) was used for
statistical analysis. The Kolmogorov–Smirnov test was performed to test
the normality of continuous variables. Continuous variables are reported
as median and interquartile range (IQR) or mean and standard deviation
(SD), and nominal values are reported as counts and percentages. Survival
and freedom from valve-related reoperation was assessed with the
Kaplan–Meier estimate. To compare differences between the 2 study
groups, either the Mann–Whitney U test or independent samples t test
for continuous variables, c2 or Fisher exact test for categorical variables,
and log-rank test for Kaplan–Meier estimates were used. The a-level
was set at 0.05 for statistical significance.
To reduce selection bias, a control group for patients in the robotic
group was selected using propensity score matching. Propensity scorestral valve operations and mitral valve operations with concomitant tricuspid
015.
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TABLE 2. Patient characteristics and risk factors
Patient characteristics Robotic group (n ¼ 142) Control group (n ¼ 142) P value Standardized difference
Sex*
Male 115 (80.9) 113 (79.5) .882 0.04
Age, y* 59.0 (10.8) 59.4 (10.3) .984 0.04
BSA, m2* 1.99 (0.22) 1.99 (0.29) .942 0.02
GFR, mL/min* 89 (76-110) 88 (72-111) .899 0.02
Logistic EuroSCORE I, %* 2.08 (1.51-3.09) 2.23 (1.51-3.19) .378 0.01
Atrial fibrillation* 47 (33.1) 46 (32.4) 1.000 0.02
Ejection fraction* .832 0.05
>50% 129 (90.8) 131 (92.3)
50% 13 (9.2) 11 (7.7)
NYHA* .741
I 18 (12.7) 13 (9.2) 0.11
II 63 (44.4) 61 (43.0) 0.03
III 56 (39.4) 63 (44.4) 0.10
IV 5 (3.5) 5 (3.5) 0
Diabetes 6 (4.2) 5 (3.5) 1.000
Hypertension 48 (33.8) 39 (27.5) .303
Chronic lung disease 7 (4.9) 19 (13.4) .022
Myocardial infarction 1 (0.7) 0 1.000
Stroke 1 (0.7) 1 (0.7) 1.000
History of PCI 0 1 (0.7) 1.000
Previous cardiac surgery 0 0 1.000
MR .518
Grade 1þ 0 0
Grade 2þ 1 (0.7) 0
Grade 3þ 87 (61.3) 83 (58.5)
Grade 4þ 54 (38.0) 59 (41.5)
Carpentier classification 1.000
I 2 (1.4) 1 (0.7)
II 140 (98.6) 141 (99.3)
Mitral pathology (Carpentier II) .182
Posterior leaflet 120 (84.5) 109 (76.8)
Anterior leaflet 11 (7.7) 16 (11.3)
Bileaflet 9 (6.3) 16 (11.3)
LA diameter, mm 49.9 (7.1) 51.7 (7.8) .141
Data shown as number of patients (%) or mean  standard deviation (range) or median (interquartile range). BSA, Body surface area; GFR, glomerular filtration rate;
EuroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; MR, mitral valve regur-
gitation; LA, left atrium. *Propensity-matched variables.




for each patient in the robotic group and for the 317 sternotomy patients
were calculated using 8 preselected variables listed in Tables 2 and 3,
including sex, age, body surface area, glomerular filtration rate, logistic
EuroSCORE I, atrial fibrillation, ejection fraction, and New York Heart
Association class. The resulting propensity scores were used to select
control patients for the 142 patients in the robotic group in a 1:1 ratio us-
ing 0.02 match tolerance. Matching was performed with the nearest-
neighbor algorithm without replacement and resulted in a well-matched
control group of 142 patients with regard to all 8 variables used in the pro-
pensity score matching. Standardized differences were calculated to
assess the quality of the propensity score matching, and values< 0.1
were considered a good match.1466 The Journal of Thoracic and Cardiovascular SurRESULTS
Operative Data
Operative data are presented in Table 4. In the robotic
group, mitral valve repair was performed successfully in
140 operations of the 142 intended repairs, with a repair
rate of 98.6%. The remaining 2 patients received a
biological prosthesis after an unsuccessful mitral repair.
Correspondingly, in the sternotomy group 2 patients
received a biological prosthesis, and 1 patient received a
mechanical prosthesis after unsuccessful mitral repairgery c April 2018
VIDEO 1. Robotic mitral valve repair. Video available at: http://www.
jtcvsonline.org/article/S0022-5223(17)32410-8/fulltext.






with a repair rate of 97.9% for the sternotomy group. Table
4 presents the different mitral valve repair techniques used
in the operations. In both study groups, mostly either neo-
chord implantation or leaflet resection were performed to
treat mitral regurgitation. Neochordae were implanted
more frequently in the robotic group in comparison with
the sternotomy group (78 [55.7%] vs 54 [38.8%]), whereas
leaflet resection was performed more often in the
sternotomy group (52 [37.1%] vs 86 [61.9%] in the robotic
and sternotomy groups, respectively).
Concomitant surgery included 35 (24.6%) versus 30
(21.1%) atrial fibrillation ablation procedures, 14 (9.9%)
versus 7 (4.9%) patent foramen ovale closures, and
6 (4.2%) versus 17 (12.0%) tricuspid valve annuloplasties
in the robotic and sternotomy groups, respectively.
There was one concomitant myxoma excision andTABLE 3. Baseline patient characteristics before propensity score matchi
Patient characteristics Robotic group (n ¼ 142) Prematc
Sex
Male 115 (80.9)
Age, y 59.0 (10.8) 6
BSA, m2 1.99 (0.22) 1
GFR, mL/min 83 (72-93)
Logistic EuroSCORE I, % 2.08 (1.51-3.09) 2









Data shown as number of patients (%) or mean  standard deviation (range) or medi
EuroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New York
The Journal of Thoracic and Carone pericardial cyst excision in the robotic group. In the
sternotomy group, one concomitant thymoma excision
was performed.
The procedure-related times, ventilation, intensive care
unit, and hospitalization times for both study groups are
listed in Tables 4 and 5. Operation length, cardiopulmonary
bypass time, aortic crossclamp time, and ventilation time
were all statistically significantly shorter in the sternotomy
group, whereas patients in the robotic group were
transferred earlier from the intensive care unit to the
ward. The total volume of chest tube drainage was similar
between the study groups during the first postoperative
16 hours. There was no statistically significant difference
in the number of patients requiring more than 1 unit of
red blood cells during hospitalization between the study
groups.
During the first 30 robotic operations, intraoperative
times tended to shorten, and after the first 30 operations a
steady state was reached. To describe the learning
curve concerning robotically assisted operations, operation-
related times of the first 30 robotic operations and the
last 112 robotic operations are presented in Table 6.
Operation length, console time, cardiopulmonary bypass
time, crossclamp time, and ventilation time were all
statistically significantly reduced during the learning curve.Conversions and Complications
In all, 13 robotically assisted operations were converted
to sternotomy, and 1 operation was converted to
thoracotomy with a conversion rate of 9.9%. As our series
includes the early part of the learning curve, the threshold ofng
hed control (n ¼ 317) P value Standardized difference
223 (70.3) .016 0.25
2.4 (11.4) .001 0.30
.94 (0.25) .032 0.19
79 (65-91) .009 0.24
.23 (1.51-3.19) <.001 0.33









an (interquartile range). BSA, Body surface area; GFR, glomerular filtration rate;
Heart Association.
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TABLE 4. Operative data
Variable Robotic group (n ¼ 142) Control group (n ¼ 142) P value
Operation length, min 254 (227-290) 217 (173-251) <.001
Console time, min 129 (112-154) –
CPB time, min 157 (135-181) 112 (93-154) <.001
Crossclamp time, min 104 (87-120) 86 (67-109) <.001
Mitral procedure .605
Repair 140 (98.6) 139 (97.9)
Bioprosthesis 2 (1.4) 2 (1.4)
Mechanical prosthesis 0 1 (0.7)
Concomitant surgery
AF ablation 35 (24.6) 30 (21.1) .480
PVI 0 5 (3.5) .060
Left atrial maze 35 (24.6) 23 (16.2) .105
Biatrial maze 0 4 (2.8) .123
Tricuspid repair 6 (4.2) 17 (12.0) .028
PFO closure 14 (9.9) 7 (4.9) .172
LAA ligation 32 (22.5) 26 (18.3) .392
Myxoma excision 1 (0.7) 0 1.000
Thymoma excision 0 1 (0.7) 1.000
Pericardial cyst excision 1 (0.7) 0 1.000
Mitral valve repair technique (n ¼ 140) (n ¼ 139)
Neochord implantation 78 (55.7) 54 (38.8) .004
Anterior leaflet 16 (11.4) 29 (20.9) .032
Posterior leaflet 65 (46.4) 30 (21.6) <.001
Annuloplasty 139 (99.3) 139 (100) 1.000
Leaflet resection 52 (37.1) 86 (61.9) <.001
Commissuroplasty 18 (12.9) 19 (13.7) .860
Cleft closure 42 (30.0) 37 (26.7) .530
Leaflet plication 5 (3.6) 5 (3.6) 1.000
Edge to edge 0 1 (0.7) 1.000
Data shown as number of patients (%) or mean  standard deviation (range) or median (interquartile range). CPB, Cardiopulmonary bypass; AF, atrial fibrillation;
PVI, pulmonary vein isolation; PFO, patent foramen ovale; LAA, left atrial appendage.




conversion to full sternotomy was kept low to maximize the
safety of the procedure. Five conversions were due to
problems with endoclamp positioning and cardioplegia
delivery. Four operations were converted after suboptimal
mitral valve repair. In 2 of these operations, a mitral valve
replacement was performed and 2 valves were re-repaired
via sternotomy. There were 2 conversions for bleeding, 1
conversion due to pleural adhesions, 1 due to problems
with venous return, and 1 because of robotic malfunction.
A total of 11 patients in the robotic group and 8 patients
in the sternotomy group required reoperations due to
bleeding (Table 5). Eight patients in the robotic group
were reoperated due to pleural hematoma. Two patients
who underwent conversion to sternotomy were reoperated
due to retrosternal bleeding during hospitalization. One
patient in the robotic group required resternotomy after
pericardial effusion and cardiac tamponade. In the
sternotomy group, 5 patients underwent resternotomy due
to retrosternal bleeding, and 1 patient required thoracotomy
for pleural hematoma. Two patients in the robotic group and
6 patients in the sternotomy group required1468 The Journal of Thoracic and Cardiovascular Sursubxiphoidal fenestrations due to pericardial effusion
postoperatively.
In the robotic group, low cardiac output and iatrogenic
injuries were more common than in the open group
(7/142 vs 1/142, respectively, P ¼ .066, Table 5). In the
robotic group, a total of 3 patients required extracorporeal
membrane oxygenator (ECMO) support postoperatively
due to low cardiac output (Table 5). One of these patients
died during hospitalization due to multiorgan failure after
2 reoperations due to bleeding and after implantation of a
left ventricular assist device. The other 2 patients requiring
ECMO support were discharged after prolonged hospitali-
zation (16 days and 31 days) with no MR. In 2 robotically
assisted operations, the left circumflex coronary artery
was occluded during annuloplasty. One of these patients
was treated with percutaneous coronary intervention and a
coronary stent placement, and the other required a coronary
artery bypass grafting operation after an unsuccessful
percutaneous coronary intervention. In 3 robotic operations,
an intra-aortic balloon pump was applied intraoperatively











ICU stay, d 1 (1-1) 1 (1-2) .011
Ventilation time, h 15 (12-20) 13 (10-17) .001
Hospitalization time, d 7 (6-8) 7 (6-9) .190
Chest tube 16-h drainage, mL 580 (420-825) 550 (415-800) .396
Red blood cell requirement
2 units 41 (28.9) 38 (26.8) .746









30-d mortality 1 (0.7) 0 1.000
Perioperative stroke 0 1 (0.7) 1.000
Perioperative MI 1 (0.7) 3 (2.1) .622
Low cardiac output syndrome 4 (2.8) 1 (0.7) .371
IABP implantation 3 (2.1) 1 (0.7) .622
Sepsis 2 (1.4) 0 .498
Empyema 1 (0.7) 0 1.000
Pneumonia 5 (3.5) 0 .060
Wound infection 2 (1.4) 1 (0.7) 1.000
Dialysis 3 (2.1) 3 (2.1) 1.000
LCx occlusion 2 (1.4) 0 .498
Femoral artery occlusion 1 (0.7) 0 1.000
Reoperations
Due to bleeding 11 (7.7) 8 (5.6) .636
ECMO implantation 3 (2.1) 0 .247
PM implantation 1 (0.7) 2 (1.4) 1.000
LCx occlusion 2 (1.4) 0 .498
Cross-over bypass 1 (0.7) 0 1.000
Data shown as number of patients (%) or mean  standard deviation (range) or
median (interquartile range). ICU, Intensive care unit;MR, mitral valve regurgitation;
MI, myocardial infarction; IABP, intra-aortic balloon pump; LCx, left circumflex
coronary artery; ECMO, extracorporeal membrane oxygenator; PM, pacemaker.






patient in the sternotomy group required an intra-aortic
balloon pump postoperatively. One patient in the robotic
group required crossover bypass after arterial occlusion of
the right femoral artery. Two patients in the sternotomy
group and 1 patient in the robotic group underwent a
pacemaker implantation due to atrioventricular block.
Infectious complications were more frequent in the
robotic group (P ¼ .066, Table 5). In the robotic group,
altogether 7 patients had postoperative infectious
complications including 2 superficial wound infections, 5
cases of pneumonia, 1 catheter-related sepsis, and 1
empyema and sepsis. In the sternotomy group, 1 patient
had a superficial wound infection. Three patients in theThe Journal of Thoracic and Carrobotic group and 2 patients in the sternotomy group
required dialysis due to renal insufficiency postoperatively.
A total of 1 and 3 patients had perioperative myocardial
infarction in the robotic and sternotomy groups,
respectively. There were no cerebrovascular events in the
robotic group, but 1 patient in the sternotomy group had a
computed tomography–confirmed stroke perioperatively.
Follow-up and Valve-Related Reoperations
Follow-up results are presented in Table 7. Patients in the
robotic surgery group who were converted to open
sternotomy or thoracotomy were included in the
follow-up data of the robotic group. At the latest
echocardiographic follow-up visit (median 15 [IQR 3-23]
months vs 21 [IQR 7-57] months), 86.3% versus 84.7%
of patients had grade 1þ or less MR in the robotic and
sternotomy groups, respectively. Follow-up data were
available from 92.3% versus 83.1% patients in the robotic
and sternotomy groups, respectively. Six (4.1%) patients
in the robotic group and 10 (7.0%) patients in the
sternotomy group required reoperations due to residual
MR during follow-up (mean 35 [SD 17] months vs 64
[SD 35] months, for the robotic and sternotomy groups,
respectively). Because of the difference in lengths of
the follow-up periods, survival and freedom from
reoperation were evaluated with the Kaplan–Meier
estimate. Figures 2 and 3 illustrate Kaplan–Meier curves
for survival and freedom from valve-related reoperation,
respectively. During follow-up, there was no statistically
significant difference in survival or in valve-related
reoperation rate between the 2 study groups (P ¼ .656
and P ¼ .841, respectively).
COMMENT
This study presents the results and early learning curve of
robotic mitral valve repair operations in comparison with
propensity-matched controls. The resulting propensity-
matched control group and the robotic group were similar
regarding the 8 variables used in the propensity score match-
ing. Repair rate was high in both study groups, but the repair
techniques differed between the study groups. Neochordae
were implanted more commonly in the robotic group,
whereas leaflet resection was performed more often in the
sternotomy group. The conversion rate was high, and more
than one third of the conversions were endoclamp-related.
The procedure-related times and ventilation times were
shorter in the sternotomy group, but a statistically significant
reduction of these times was observed in the robotic group
during the learning curve. Even though there was no
statistically significant difference in the overall rate of
perioperative complications between the robotic and
sternotomy groups, in the robotic group, 3 patients required
postoperative ECMO support, 2 patients suffered from left
circumflex coronary artery occlusion, and 1 patient died.diovascular Surgery c Volume 155, Number 4 1469
TABLE 6. Learning curve
Variable
Robotic group
5/2011 to 5/2012 (n ¼ 30)
Robotic group
6/2012 to 12/2015 (n ¼ 112) P value
Operation length, min 277 (247-349) 250 (224-281) .002
Console time, min 150 (124-215) 122 (110-147) <.001
CPB time, min 171 (148-199) 151 (133-175) .002
Crossclamp time, min 111 (95-138) 101 (86-116) .045
Ventilation time, h 20 (14-24) 14 (12-17) .001
ICU time, d 1 (1-2) 1 (1-1) .070
Hospitalization time, d 7 (6-8) 7 (6-8) .907
Chest tube 16-h drainage, mL 620 (475-1035) 573 (413-818) .238
Data shown as median (interquartile range). CPB, Cardiopulmonary bypass; ICU, intensive care unit.




During follow-up, survival and freedom from valve-related
reoperation were similar between the 2 study groups.
Previously, similar complication and reoperation rates have
been reported in robotic and sternotomy mitral valve repair
operations.1,2,5 In addition, excellent mid-term results after
robotic mitral valve repair have been reported by high-
volume centers.2-5,7 In this study, we aimed to report all
complications in detail. Even though the difference in the
overall rate of complications was statistically not
significant, the robotic technique was associated with some
major complications that may be related to both the
learning curve and to a different approach in the robotic
group with regard to both cardioplegia and repair
techniques. Our study presents the early learning curve
related to the introduction of robotic mitral valve repair,
which explains the reduction of intraoperative times during
the learning curve within the robotic group. However,
despite taking this reduction into consideration, the
operative and ventilation times observed in this study are
longer than those reported by high-volume centers.2-5,7
Unexpectedly, 3 patients in the present series required
postoperative ECMO support due to low cardiac output.
This underlines the importance of myocardial protection.
To improve myocardial protection, in our series single-
dose Bretschneider cold cardioplegia was replaced with
intermittent cold antegrade and retrograde blood
cardioplegia and the perfusion temperature was lowered.
The greatest limitation of this study is its retrospective






(n ¼ 118) P value
Grade 1þ or less 113 (86.3) 100 (84.7) .857
Grade 2þ 5 (3.8) 4 (3.4) 1.000
Grade 3þ 5 (3.8) 2 (1.7) .451
Grade 4þ 2 (1.5) 1 (0.8) 1.000
Reoperated 7 (5.3) 10 (8.5) .619
Data shown as number of patients (%).
1470 The Journal of Thoracic and Cardiovascular Surrepair were selected. Even though propensity score
matching resulted in well-matched pairs of study patients
and controls, it does not eliminate the effect of inherent
intention-to-treat or selection bias. The 8 variables that
were used to calculate the propensity score may not include
all relevant risk factors affecting the outcome of mitral
valve surgery. Mitral valve anatomy and the presence of
concomitant operations were not included in the propensity
score, which is a limitation. Also, it was not possible to
match the groups based on operative variables such as
cardioplegia delivery and aortic occlusion strategy. There
might also be risk factors that remain unrecognized and
are therefore missing from our data. An important
limitation of this study is that the mitral valve repair
techniques were significantly different between the groups.
In the robotic group, more nonresection techniques were
used. Also, cardioplegia and aortic occlusion strategies
were different in the 2 groups. In addition, fewer
concomitant tricuspid operations were performed in the
robotic group. Patients in the control group were also
more historical in comparison with the patients in the
robotic group because of the smaller number of sternotomyFIGURE 2. Survival.
gery c April 2018
FIGURE 3. Freedom from valve-related reoperation.






mitral operations after the introduction of robotic mitral
surgery at our institution. To take into account the
resulting differences in the lengths of the follow-up periods,
Kaplan–Meier estimates for survival and freedom from
valve-related reoperations were constructed with no statis-
tically significant differences between the study groups.
Data from the latest echocardiographic follow-up visits
were available from 92.3% versus 83.1% patients in the ro-
botic and sternotomy groups, respectively. Because of the
partly missing follow-up data, the number of patients at
risk is reduced in the Kaplan–Meier analyses. This leads
to a significant reduction of statistical power with
increasing follow-up time.
The safety of robotic mitral valve repair was inferior to
that of open repair in this series. In our experience, we
initiated robotic instrumentation and the use of an endoartic
balloon simultaneously, which resulted in overlapping
learning curves of these 2 new technologies. Also,
myocardial protection methods evolved during our
experience. We recommend that similar institutions with a
limited annual count of mitral valve operations would start
their robotic mitral valve program with a dedicated and
constant surgical team. Only one console surgeon with an
underlying intensive training period might be preferable
in the beginning of the learning curve. We also recommend
that there are dedicated perfusionist, anesthesiologist, and
scrub nurse teams involved. Also, we suggest that the use
of an endoaortic balloon should not be started at the same
time as a robotic surgery program is initiated due to
overlapping learning curves. An anesthesiologist with
comprehensive skills with the transesophageal ultrasound
is required in the operating room not only during the
placement of the endoaortic balloon but also during the
whole surgical procedure. Every effort should be made to
detect endoballoon migration and to ensure adequateThe Journal of Thoracic and Carcardioplegia delivery, adequate drainage, and adequate
cooling. Finally, very careful patient selection is warranted.
The present series reports the entire early learning curve
related to the introduction of robotic mitral valve repair with
intra-aortic occlusion in our institution. In all, repair rate
and valve-related follow-up results were acceptable, but
some major complications occurred in the robotic group.Conflict of Interest Statement
Drs Vento and Sahlman are Proctor of Intuitive Surgical
2014. All other authors have nothing to disclose with regard
to commercial support.References
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